Appeal No. 1996-0721
Application No. 08/036,640
R-SO -NH-CO-NH-R
2 1
in which” R is, inter alia, a substituted or unsubstituted
phenyl, aliphatic or cycloaliphatic hydrocarbon radical and R1
is
-(CH) C H . See column 1, lines 19-51. According to the
n 65
examiner (Answer, page 3):
The sole difference between [sic, the] herein
recited claims and the [Korger] reference appears to
be in the definition of R in the reference.
1
To remedy this deficiency of the Korger reference, the
examiner relies on the disclosures of McLamore and Lucius.
McLamore describes medicinal agents for reducing blood sugar
levels having a formula
RSO NHCONHR’,
2
wherein R’ is “a lower alkyl, lower alkenyl or cycloalkyl
group or it is an aryl group.” See pages 1 and 2. Similarly,
Lucius describes compounds for lowering blood sugar having a
formula RSO NHCONHR ,2 1
wherein R is “saturated or unsaturated alkyl, cycloalkyl,1
cycloalkylalkyl, phenylalkyl or phenyl group...” See page 2.
Nowhere do these references teach, or would have suggested,
employing the claimed halophenyl radical as R of the general
1
5
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007